|
 |
Advocacy |
ANCO serves as an advocate and liaison before regional and national organizations (i.e., government, private, and corporate) and plays an active role in the reimbursement environment on behalf of hematologists/oncologists, nurses, practice managers, and people living with cancer. The Board deliberates on and recommends policies, and is represented and communicates these policies at a variety of national and state forums, including ACCC meetings, ASCO's Clinical Practice Committee meetings, California Medical Association (CMA) meetings, and the California legislature and regulatory bodies. It also represents the interests of its member before private payers.
|
|
National Advocacy |
ANCO, as a state/regional affiliate of the American Society of Clinical Oncology (ASCO) works with ASCO before Congress and the Centers for Medicare and Medicaid Services (CMS) on cancer issues. Use ASCO's ACT Network engage with Congressional Represenatatives on current legsilation impacting cancer care.
For latest and best information on Medicare, visit ASCO's Medicare Program webpage or ANCO's Medicare & Oncology webpage. ASCO has also developed a comprehensive list of practice guidelines that may be used with local Medicare, Medicaid, and private carriers.
Back to Top
|
|
|
CalCancerPAC |
ANCO and MOASC have established the California Oncology Political Action Committee (or CalCancerPAC). Fundraising efforts were launched in late 2005 and will support candidates in California that support oncology.
Back to Top
|
|
Private Payers |
ANCO communicates with private insurance companies as needed on issues brought to its attention by the membership. While ANCO cannot negotiate on behalf of its members with respect to reimbursement and payment, it can argue on their behalf with respect to access to quality cancer care and those factors that may interfere with such care.
ANCO, incooperation with MOASC, has successfully advocated for the passage of several laws in California that call for prompt payment, independent review, off-label coverage, and coverage of routine care costs for patients enrolled in clinical trials. Click here to download a PowerPoint presentation summarizing these laws.
Back to Top
|
|
|
|